Botulinum toxin (BoNT) is used for a range of applications, but when injected it can diffuse into the surrounding tissue and give rise to adverse effects. A new study shows that a subtle modification of an FDA-approved form of BoNT enhances binding to the nerve cells and improves the drug’s potency and safety.